BCIQ Profiles

Company Profile Report
0615 VectorY Forbion
BioCentury & Getty Images

Emerging Company Profile

VectorY: Forbion’s next-generation gene therapy play

Emerging Company Profile: With €31M, VectorY builds a toolbox to develop, manufacture vectorized antibodies

With €31M, VectorY builds a toolbox to develop and manufacture vectorized antibodies.

Jun 15, 2021 | 9:12 PM GMT

Forbion-backed VectorY is assembling a set of tools and key personnel to create vectorized antibody therapeutics designed

Read the full 591 word article

How to gain access

Continue reading with a
two-week free trial.